サインイン 無料でサインアップします。

Acelrx Pharmaceuticals Incの営業利益

Acelrx Pharmaceuticals Incの営業利益は何ですか。

Acelrx Pharmaceuticals Incの営業利益は-3,221.70%です。

営業利益の定義は何ですか。



営業利益率は、営業利益を純売上高で除したもので、パーセントで表しています。

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

NASDAQのセクタHealth Careにおける営業利益の企業と比べるAcelrx Pharmaceuticals Inc

Acelrx Pharmaceuticals Incは何をしますか。

acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v

Acelrx Pharmaceuticals Incと類似の営業利益